XBiotech competitorsClear all

XBiotech's top competitors include Aptevo Therapeutics, Geron, Aeglea Biotherapeutics and Heat Biologics.
XBiotech
XBiotech
XBiotech is a biopharmaceutical company developing first-in-class antibody therapies.
Aptevo Therapeutics
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Geron
Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Aeglea Biotherapeutics
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
Heat Biologics
Heat Biologics
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.
Founding Date
Founding Date
2005
Founding Date
2016
Founding Date
1990
Founding Date
2013
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Austin, US HQ
Locations
Seattle, US HQ
Locations
Menlo Park, US HQ
Canton, US
Locations
Austin, US HQ
Locations
Durham, US HQ
Employees
Employees
595% increase
Employees
1182% decrease
Employees
1713% increase
Employees
619% increase
Employees
3058% increase
Valuation ($)
Valuation ($)
259.7 m
Valuation ($)
38.3 m
Valuation ($)
261.1 m
Valuation ($)
200.6 m
Valuation ($)
24.2 m
Alexa Website Rank
Alexa Website Rank
1073009
Alexa Website Rank
746331
Alexa Website Rank
233956
Alexa Website Rank
714531
Alexa Website Rank
944256

Financial

Net income
Net income
($21.1m) (FY, 2018)
Net income
($53.7m) (FY, 2018)
Net income
($27m) (FY, 2018)
Net income
($44.3m) (FY, 2018)
Net income
($16.6m) (FY, 2018)
For sources of this data, please see the company profile

View company profiles

Aptevo Therapeutics
HQ
Seattle, US
Employees
118↓ 2% decrease

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

View company
Geron
HQ
Menlo Park, US
Employees
17↑ 13% increase

Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

View company
Aeglea Biotherapeutics
HQ
Austin, US
Employees
61↑ 9% increase

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.

View company
Heat Biologics
HQ
Durham, US
Employees
30

Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.

View company